Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
自噬在 2 型糖尿病微血管功能障碍中的作用
基本信息
- 批准号:10673182
- 负责人:
- 金额:$ 10.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgonistAnimal ModelArteriesAutophagocytosisBasic ScienceBiogenesisBlood VesselsCardiomyopathiesCardiovascular systemChloroquineClinicalClinical SciencesClinical TrialsCollaborationsComplementCoupledCutaneousDataDefectDevelopment PlansDiabetes MellitusDilatorDiseaseDisease ProgressionEducationEndotheliumEnsureEnvironmentEventExposure toFacultyFunctional disorderFutureGeneticGlucoseGoalsHealthHumanHuman Subject ResearchHydrogen PeroxideHyperemiaHyperglycemiaImpairmentInvestigationKnowledgeLaboratoriesLaser-Doppler FlowmetryLasersLearningLysosomesMaintenanceMediatingMediatorMentorsMentorshipMicrocirculationMicrodialysisMicrovascular DysfunctionMitochondriaMolecularNatureNitric OxideNon-Insulin-Dependent Diabetes MellitusOralOxidation-ReductionOxidative Stress InductionPathologicPhasePhysiologicalPhysiologyPositioning AttributePostdoctoral FellowProductionReactive Oxygen SpeciesRepressionResearchResearch PersonnelResistanceRetinal DiseasesRisk FactorsRoleScienceScientistSenior ScientistSeriesTechnical ExpertiseTechniquesTrainingTranslatingTrehaloseVascular DiseasesVascular EndotheliumVasodilationViralarteriolecardiovascular disorder riskcardiovascular risk factorcareercareer developmentendothelial dysfunctionexperiencegene repressionin vivoinhibition of autophagymicrovascular pathologymortalitymultidisciplinarynoveloverexpressionpharmacologicpost-doctoral trainingpreservationprogramsresponsesabbaticalshear stressskillstranscription factortranslational modeltranslational studyvascular endothelial dysfunction
项目摘要
Project Summary
This K99/R00 application proposes a comprehensive career development plan and a series of investigations,
coupled with an outstanding mentoring committee specifically tailored to assist completion of postdoctoral
training and establish an independent research program. This proposal is multi-faceted, leveraging previous
training in human subjects research to complement current postdoctoral training to investigate the fundamental
mechanisms underlying microvascular dysfunction in Type 2 Diabetes Mellitus (T2DM). Autophagic flux is
necessary to maintain a healthy microvascular environment. T2DM is associated with reductions in autophagic
flux, however whether this underlies the rampant microvascular defects associated with the disease is unclear.
During the K99 phase we will examine whether T2DM is associated with a pathological switch in the mechanism
of microvascular vasodilation to shear stress in isolated arterioles, and examine whether autophagic flux
contributes to cutaneous microvascular function in T2DM using laser Doppler flux coupled with microdialysis. Dr.
Hughes will train under the mentorship of a transdisciplinary group of senior scientists with research expertise in
mechanisms of microvascular dysfunction, and examination of cutaneous microvascular function within the
context of T2DM. The current postdoctoral mentors, Drs. David Gutterman and Andreas Beyer, both of whom
have extensive experience mentoring trainees will continue to serve as mentors. They will be complemented by
mentoring expertise from Naomi Hamburg and Lacy Alexander. The primary goal is to become an expert in the
field of human microvascular physiology within the context of T2DM. This will be achieved through 1) expansion
of technical skills including molecular techniques, along with laser Doppler flowmetry coupled with microdialysis;
and 2) empirical training in lab and clinical trial management, along with team science and mentoring skills.
Achieving these goals will strengthen further scholarly activities, establish important collaborations, and acquire
critical data that will ensure a successful transition to independence. The training plan will be strengthened
through a sabbatical in the laboratory of Dr. Lacy Alexander, where Dr. Hughes will be trained in investigation of
microvascular function in the human cutaneous microvasculature. Obtaining an independent educational
experience in one of the world’s most successful laboratories that utilize this technique will strengthen the ability
to conduct translational studies. Collectively, this team will provide an outstanding training environment that will
fill critical gaps in knowledge and skill set relating to the mechanisms contributing to microvascular dysfunction
in T2DM. For the transition to independence phase, the mechanistic contribution of Transcription Factor EB
(TFEB), a master regulator of lysosome biogenesis, will be investigated utilizing the skills and techniques learned
and mastered during the K99 phase. The components of this application are consistent with the career goals of
becoming an independent investigator whose research intersects basic and clinical science.
项目摘要
本K99/R 00申请提出了全面的职业发展计划和一系列的调查,
再加上一个杰出的指导委员会专门为协助完成博士后
培训和建立独立的研究计划。该提案是多方面的,利用了以前的
培训人类受试者的研究,以补充目前的博士后培训,调查的基本
2型糖尿病(T2 DM)微血管功能障碍的潜在机制。自噬通量是
维持健康的微血管环境。T2 DM与自噬细胞减少相关
然而,这是否是与该疾病相关的猖獗的微血管缺陷的基础尚不清楚。
在K99阶段,我们将检查T2 DM是否与机制中的病理转换相关。
的微血管扩张的剪切应力在孤立的小动脉,并检查是否自噬流量
使用激光多普勒流量结合微透析有助于T2 DM患者的皮肤微血管功能。博士
休斯将在一个由资深科学家组成的跨学科小组的指导下进行培训,这些科学家具有以下方面的研究专长:
微血管功能障碍的机制,并检查皮肤内的微血管功能,
关于T2 DM现任博士后导师大卫·古特曼博士和安德烈亚斯·拜尔博士,
具有丰富指导经验的学员将继续担任导师。这些建议将得到以下方面的补充:
娜奥米·汉堡和莱西·亚历山大的专业指导。主要目标是成为一个专家,
T2 DM背景下的人体微血管生理学领域。这将通过1)扩展
技术技能,包括分子技术,沿着激光多普勒血流仪与微透析;
和2)实验室和临床试验管理的经验培训,沿着团队科学和指导技能。
实现这些目标将加强进一步的学术活动,建立重要的合作,并获得
确保成功过渡到独立的关键数据。培训计划将得到加强
通过在莱西亚历山大博士的实验室休假,休斯博士将在那里接受调查培训。
在人类皮肤微血管系统中的微血管功能。获得独立的教育
在世界上最成功的实验室之一利用这种技术的经验将加强能力
进行翻译研究。总的来说,这个团队将提供一个出色的培训环境,
填补与微血管功能障碍机制相关的知识和技能方面的关键空白
2型糖尿病对于向独立阶段的过渡,转录因子EB的机制贡献
(TFEB),溶酶体生物发生的主调节器,将利用所学的技能和技术进行研究
并在K99阶段掌握。此应用程序的组成部分与以下职业目标一致:
成为一个独立的研究者,其研究交叉基础和临床科学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William E Hughes其他文献
William E Hughes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William E Hughes', 18)}}的其他基金
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
自噬在 2 型糖尿病微血管功能障碍中的作用
- 批准号:
10523896 - 财政年份:2022
- 资助金额:
$ 10.76万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 10.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 10.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 10.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




